DCTH
Closed
Delcath Systems Inc
12.76
-0.84 (-6.18%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.6
Day's Range: 12.65 - 13.46
Send
sign up or login to leave a comment!
When Written:
5.75
Delcath Systems Inc. is a medical technology company that specializes in the development and commercialization of innovative therapies for the treatment of cancer. The company's primary focus is on the treatment of liver cancer, which is one of the most difficult-to-treat forms of cancer.
Delcath's flagship product is the Hepatic ChemoSAT Delivery System, which is a minimally invasive, catheter-based system that delivers high-dose chemotherapy directly to the liver. This targeted approach minimizes the exposure of healthy tissue to chemotherapy, while maximizing the concentration of the drug in the tumor.
The company is headquartered in New York City and has operations in Europe and Asia. Delcath is publicly traded on the NASDAQ stock exchange under the ticker symbol DCTH.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Delcath's flagship product is the Hepatic ChemoSAT Delivery System, which is a minimally invasive, catheter-based system that delivers high-dose chemotherapy directly to the liver. This targeted approach minimizes the exposure of healthy tissue to chemotherapy, while maximizing the concentration of the drug in the tumor.
The company is headquartered in New York City and has operations in Europe and Asia. Delcath is publicly traded on the NASDAQ stock exchange under the ticker symbol DCTH.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








